Dyne Therapeutics (DYN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: SVP of $DYN Sells 2,488 Shares
Quiver QuantitativeFeb 18 17:17 ET
Dyne Therapeutics Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution
Simply Wall StFeb 17 10:51 ET
Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
GlobeNewswireFeb 3 07:30 ET
Down -42.2% in 4 Weeks, Here's Why Dyne Therapeutics (DYN) Looks Ripe for a Turnaround
Zacks Jan 28 08:40 ET
Express News | Guggenheim Reiterates Buy on Dyne Therapeuticsto Buy
BenzingaJan 24 11:09 ET
Express News | Dyne Therapeutics Inc : JP Morgan Cuts Target Price to $18 From $34
ReutersJan 22 06:43 ET

Comments

Jaguar8

Jan 21 07:14

NEWS

$Dyne Therapeutics (DYN.US)$
Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
Dyne Therapeutics (Nasdaq: DYN) has received FDA Fast Track designation for DYNE-101, their treatment candidate for myotonic dystrophy type 1 (DM1). The designation follows positive clinical data from their ongoing Phase 1/2 ACHIEVE global trial, which showed substantial functional benefits and splicing correction in patients.
The company plans to su...

2

Trytosaveabit

Jan 21 06:34

news

$Dyne Therapeutics (DYN.US)$ Reuters· 3 mins ago
Dyne Therapeutics Receives FDA Fast Track Designation for Dyne-101 for the Treatment of Myotonic Dystrophy Type 1

Spinee

Jul 15, 2024 02:41

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...

2

Trytosaveabit

May 20, 2024 12:31

$Dyne Therapeutics (DYN.US)$ Looking like a nice market response to the news/update

Trytosaveabit

May 20, 2024 05:42

News

$Dyne Therapeutics (DYN.US)$ Dyne Therapeutics Announces New Clinical Data From ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
GlobeNewswire· 7 mins ago
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months -
- DYNE-101 Showed Improvement in Myotonia, Muscle Strength, ...

4

2

DYN Dyne Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks